Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.
This page lists all known medications that could potentially lead to 'Mycosis fungoides' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...
Please provide your email address to receive an email when new articles are posted on . Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides ...
In a recent clinical letter published by the Brazilian Society of Dermatology, researchers highlight the potential role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in ...
Objective: Three patients with follicular mycosis fungoides (FMF), a rare variant of folliculotropic cutaneous T-cell lymphoma, are discussed. Follicular involvement in cutaneous T-cell lymphoma ...
Please provide your email address to receive an email when new articles are posted on . A post-hoc analysis of a key data set for chlormethine in mycosis fungoides showed that the gel formulation of ...
Lacutamab is a first-in-class anti-KIR3DL2 humanized cytotoxicity-inducing antibody that is currently in clinical trials for treatment of cutaneous T-cell lymphoma (CTCL), an orphan disease, and ...
The alternative text for this image may have been generated using AI. In this study, we identify recurrent alterations in the TNFR2 pathway in addition to other genes regulating T cell survival and ...
The field of measurement in Mycosis Fungoides/Sézary syndrome type cutaneous T-cell lymphoma lacked a specific quality-of-life measure to describe patient experience or guide treatment decisions.
DelveInsight's Mycosis Fungoides Market Insights report includes a comprehensive understanding of current treatment practices, mycosis fungoides emerging drugs, market share of individual therapies, ...
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Mycosis Fungoides Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results